Ken Griffin Ginkgo Bioworks Holdings, Inc. Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.06 - $1.67 $1.82 Million - $2.86 Million	1,714,091 Added 60.89%	4,529,058 $5.25 Million
Q4 2023 Feb 14, 2024	SELL	$1.26 - $1.79 $3.06 Million - $4.35 Million	-2,428,268 Reduced 46.31%	2,814,967 $4.76 Million
Q3 2023 Nov 14, 2023	BUY	$1.61 - $2.54 $6.78 Million - $10.7 Million	4,209,939 Added 407.43%	5,243,235 $9.49 Million
Q2 2023 Aug 14, 2023	BUY	$1.14 - $1.95 $130,966 - $224,021	114,883 Added 12.51%	1,033,296 $1.92 Million
Q1 2023 May 15, 2023	BUY	$1.2 - $2.19 $954,801 - $1.74 Million	795,668 Added 648.23%	918,413 $1.22 Million
Q4 2022 Feb 14, 2023	SELL	$1.63 - $3.52 $24,464 - $52,831	-15,009 Reduced 10.9%	122,745 $207,000
Q3 2022 Nov 14, 2022	SELL	$0.73 - $3.74 $1.74 Million - $8.92 Million	-2,383,851 Reduced 94.54%	137,754 $430,000

48.4M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $9.25B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.